Genscript Biotech Financials

Genscript Biotech Stock Summary

Genscript Biotech competes with Shanghai Junshi, Laboratorios Farmaceuticos, InnoCare Pharma, Camurus AB, and ALK-Abelló A/S. Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the Peoples Republic of China. Genscript Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5573 people.

Genscript Biotech Key Financial Ratios

There are many critical financial ratios that Genscript Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Genscript Biotech reports annually and quarterly.

Genscript Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Genscript Biotech's current stock value. Our valuation model uses many indicators to compare Genscript Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genscript Biotech competition to find correlations between indicators driving Genscript Biotech's intrinsic value. More Info.Genscript Biotech is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genscript Biotech's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Genscript Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genscript Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genscript Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Genscript Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genscript Biotech's daily price indicators and compare them against related drivers.

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.